• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受膀胱内卡介苗治疗浅表性膀胱癌的患者发生全身性卡介苗感染。

Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.

作者信息

Steg A, Leleu C, Debré B, Boccon-Gibod L, Sicard D

机构信息

Dept. of Urology, Hôpital Cochin, Paris, France.

出版信息

Prog Clin Biol Res. 1989;310:325-34.

PMID:2672020
Abstract

Among 169 patients treated for superficial bladder tumors with intravesical instillations of 150 mg BCG-Pasteur, five developed BCG-itis--a severe systemic infection with bronchopulmonary lesions and granulomatous hepatitis. In four cases, the complication appeared early during treatment (after three, six, six and eight instillations respectively). In one case, BCG-itis appeared 6 months after completion of 2 years monthly maintenance therapy. In addition to pulmonary basal infiltration and granulomatous hepatitis, intramedullary granulomatosis was observed. In three patients, the role of trauma has to be considered, as BCG-itis appeared after a traumatic instillation with bleeding. All patients were cured by combined treatment with Rifampicin, Isoniazid and Prednisolone.

摘要

在169例接受膀胱内灌注150mg巴斯德卡介苗治疗浅表性膀胱肿瘤的患者中,有5例发生了卡介苗病——一种伴有支气管肺部病变和肉芽肿性肝炎的严重全身感染。4例患者在治疗早期出现并发症(分别在第3、6、6和8次灌注后)。1例患者在完成2年每月维持治疗6个月后出现卡介苗病。除了肺部基底浸润和肉芽肿性肝炎外,还观察到髓内肉芽肿病。3例患者必须考虑创伤的作用,因为卡介苗病是在创伤性灌注并出血后出现的。所有患者通过利福平、异烟肼和泼尼松龙联合治疗治愈。

相似文献

1
Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer.接受膀胱内卡介苗治疗浅表性膀胱癌的患者发生全身性卡介苗感染。
Prog Clin Biol Res. 1989;310:325-34.
2
Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.膀胱癌初次膀胱内灌注卡介苗后发生分枝杆菌血症和肉芽肿性肝炎。
Am J Gastroenterol. 1993 Jul;88(7):1112-5.
3
Systemic bacillus Calmette-Guérin infection, 'BCGitis', in patients treated by intravesical bacillus Calmette-Guérin therapy for bladder cancer.接受卡介苗膀胱灌注治疗膀胱癌的患者发生的全身性卡介苗感染,即“卡介苗炎” 。
Eur Urol. 1989;16(3):161-4. doi: 10.1159/000471561.
4
[BCG infection of the glans penis after intravesical BCG therapy].[膀胱内卡介苗灌注治疗后阴茎头卡介苗感染]
Ann Dermatol Venereol. 2008 Jun-Jul;135(6-7):479-83. doi: 10.1016/j.annder.2007.06.012. Epub 2008 Mar 20.
5
Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.膀胱内卡介苗(BCG)治疗后出现膀胱和阴茎病变伴腹股沟淋巴结病。
Urology. 2007 Dec;70(6):1223.e15-7. doi: 10.1016/j.urology.2007.09.044.
6
High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG).采用膀胱内灌注卡介苗(BCG)治疗的高级别浅表性(G3t1)膀胱移行细胞癌。
J Exp Clin Cancer Res. 2003 Dec;22(4 Suppl):223-7.
7
BCG pyelonephritis following intravesical therapy for transitional cell carcinoma.膀胱内灌注治疗移行细胞癌后发生的卡介苗性肾盂肾炎。
Can J Urol. 2007 Apr;14(2):3523-5.
8
BCG-related granulomatous hepatitis.卡介苗相关的肉芽肿性肝炎。
Pneumologia. 2007 Jan-Mar;56(1):32-4.
9
Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.膀胱内卡介苗治疗T1期3级膀胱移行细胞癌:57例患者的复发、进展及生存情况研究
J Urol. 2003 Jun;169(6):2110-2. doi: 10.1097/01.ju.0000066840.42991.4a.
10
[Calmette-Guerin bacillus disseminated infection after intravesical instillation].膀胱内灌注后卡介苗播散性感染
Recenti Prog Med. 2002 Apr;93(4):247-8.

引用本文的文献

1
Infections Following Intravesical Bacillus Calmette-Guérin Instillation for Bladder Cancer in Western Australia: A 22-Year Retrospective Review.西澳大利亚州膀胱癌患者膀胱内灌注卡介苗后的感染情况:一项为期22年的回顾性研究
Open Forum Infect Dis. 2025 Feb 7;12(2):ofaf070. doi: 10.1093/ofid/ofaf070. eCollection 2025 Feb.
2
Mycotic Aneurysm after Bacillus Calmette-Guérin Treatment: Case Report and Review of the Literature.卡介苗治疗后发生的霉菌性动脉瘤:病例报告及文献复习
Case Rep Urol. 2017;2017:4508583. doi: 10.1155/2017/4508583. Epub 2017 Feb 20.
3
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
卡介苗(BCG)膀胱内灌注作为膀胱癌辅助治疗后的感染:单中心系列研究中的发病率、危险因素及结局,并对文献进行综述
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.
4
Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.膀胱尿路上皮癌的膀胱内治疗:批判性评价。
Int Braz J Urol. 2009 Nov-Dec;35(6):640-50; discussion 651. doi: 10.1590/s1677-55382009000600002.
5
Study on enhancement of fibronectin-mediated bacillus Calmette-Guérin attachment to urinary bladder wall in rabbits.增强纤连蛋白介导的卡介苗黏附兔膀胱壁的研究
World J Urol. 2007 Oct;25(5):525-9. doi: 10.1007/s00345-007-0198-z. Epub 2007 Jul 13.
6
Systemic effects of intravesical BCG treatment.膀胱内卡介苗治疗的全身效应。
Ir J Med Sci. 2002 Jul-Sep;171(3):174, 177. doi: 10.1007/BF03170515.
7
Pulmonary tuberculosis due to bacille Calmette-Guérin.卡介苗所致肺结核
Clin Investig. 1993 Oct;71(10):787-90. doi: 10.1007/BF00190319.